Head and Neck Cancer Drugs/Therapeutics Market, Global Outlook and Forecast 2022-2028

March 2022 | 62 pages | ID: H99F135AD53FEN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Head and Neck Cancer Drugs/Therapeutics in Global, including the following market information:

Global Head and Neck Cancer Drugs/Therapeutics Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Head and Neck Cancer Drugs/Therapeutics market was valued at 1064.2 million in 2021 and is projected to reach US$ 1703 million by 2028, at a CAGR of 6.9% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Surgery Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Head and Neck Cancer Drugs/Therapeutics include Sanofi, Eli Lilly, Amgen, Actavis, Dr. Reddy’s Laboratories, Jiangsu Hengrui, Teva Pharmaceutical, DFG and BioXpress. etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Head and Neck Cancer Drugs/Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Head and Neck Cancer Drugs/Therapeutics Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Head and Neck Cancer Drugs/Therapeutics Market Segment Percentages, by Type, 2021 (%)

• Surgery
• Radiation therapy
• Chemotherapy
• Immunotherapy

Global Head and Neck Cancer Drugs/Therapeutics Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Head and Neck Cancer Drugs/Therapeutics Market Segment Percentages, by Application, 2021 (%)

• Hospital
• Personal Care

Global Head and Neck Cancer Drugs/Therapeutics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Head and Neck Cancer Drugs/Therapeutics Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Head and Neck Cancer Drugs/Therapeutics revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Head and Neck Cancer Drugs/Therapeutics revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Sanofi
• Eli Lilly
• Amgen
• Actavis
• Dr. Reddy’s Laboratories
• Jiangsu Hengrui
• Teva Pharmaceutical
• DFG
• BioXpress

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Head and Neck Cancer Drugs/Therapeutics Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Head and Neck Cancer Drugs/Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL HEAD AND NECK CANCER DRUGS/THERAPEUTICS OVERALL MARKET SIZE

2.1 Global Head and Neck Cancer Drugs/Therapeutics Market Size: 2021 VS 2028
2.2 Global Head and Neck Cancer Drugs/Therapeutics Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Head and Neck Cancer Drugs/Therapeutics Players in Global Market
3.2 Top Global Head and Neck Cancer Drugs/Therapeutics Companies Ranked by Revenue
3.3 Global Head and Neck Cancer Drugs/Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Head and Neck Cancer Drugs/Therapeutics Companies in Global Market, by Revenue in 2021
3.5 Global Companies Head and Neck Cancer Drugs/Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Head and Neck Cancer Drugs/Therapeutics Players in Global Market
  3.6.1 List of Global Tier 1 Head and Neck Cancer Drugs/Therapeutics Companies
  3.6.2 List of Global Tier 2 and Tier 3 Head and Neck Cancer Drugs/Therapeutics Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Head and Neck Cancer Drugs/Therapeutics Market Size Markets, 2021 & 2028
  4.1.2 Surgery
  4.1.3 Radiation therapy
  4.1.4 Chemotherapy
  4.1.5 Immunotherapy
4.2 By Type - Global Head and Neck Cancer Drugs/Therapeutics Revenue & Forecasts
  4.2.1 By Type - Global Head and Neck Cancer Drugs/Therapeutics Revenue, 2017-2022
  4.2.2 By Type - Global Head and Neck Cancer Drugs/Therapeutics Revenue, 2023-2028
  4.2.3 By Type - Global Head and Neck Cancer Drugs/Therapeutics Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Head and Neck Cancer Drugs/Therapeutics Market Size, 2021 & 2028
  5.1.2 Hospital
  5.1.3 Personal Care
5.2 By Application - Global Head and Neck Cancer Drugs/Therapeutics Revenue & Forecasts
  5.2.1 By Application - Global Head and Neck Cancer Drugs/Therapeutics Revenue, 2017-2022
  5.2.2 By Application - Global Head and Neck Cancer Drugs/Therapeutics Revenue, 2023-2028
  5.2.3 By Application - Global Head and Neck Cancer Drugs/Therapeutics Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Head and Neck Cancer Drugs/Therapeutics Market Size, 2021 & 2028
6.2 By Region - Global Head and Neck Cancer Drugs/Therapeutics Revenue & Forecasts
  6.2.1 By Region - Global Head and Neck Cancer Drugs/Therapeutics Revenue, 2017-2022
  6.2.2 By Region - Global Head and Neck Cancer Drugs/Therapeutics Revenue, 2023-2028
  6.2.3 By Region - Global Head and Neck Cancer Drugs/Therapeutics Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Head and Neck Cancer Drugs/Therapeutics Revenue, 2017-2028
  6.3.2 US Head and Neck Cancer Drugs/Therapeutics Market Size, 2017-2028
  6.3.3 Canada Head and Neck Cancer Drugs/Therapeutics Market Size, 2017-2028
  6.3.4 Mexico Head and Neck Cancer Drugs/Therapeutics Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Head and Neck Cancer Drugs/Therapeutics Revenue, 2017-2028
  6.4.2 Germany Head and Neck Cancer Drugs/Therapeutics Market Size, 2017-2028
  6.4.3 France Head and Neck Cancer Drugs/Therapeutics Market Size, 2017-2028
  6.4.4 U.K. Head and Neck Cancer Drugs/Therapeutics Market Size, 2017-2028
  6.4.5 Italy Head and Neck Cancer Drugs/Therapeutics Market Size, 2017-2028
  6.4.6 Russia Head and Neck Cancer Drugs/Therapeutics Market Size, 2017-2028
  6.4.7 Nordic Countries Head and Neck Cancer Drugs/Therapeutics Market Size, 2017-2028
  6.4.8 Benelux Head and Neck Cancer Drugs/Therapeutics Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Head and Neck Cancer Drugs/Therapeutics Revenue, 2017-2028
  6.5.2 China Head and Neck Cancer Drugs/Therapeutics Market Size, 2017-2028
  6.5.3 Japan Head and Neck Cancer Drugs/Therapeutics Market Size, 2017-2028
  6.5.4 South Korea Head and Neck Cancer Drugs/Therapeutics Market Size, 2017-2028
  6.5.5 Southeast Asia Head and Neck Cancer Drugs/Therapeutics Market Size, 2017-2028
  6.5.6 India Head and Neck Cancer Drugs/Therapeutics Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Head and Neck Cancer Drugs/Therapeutics Revenue, 2017-2028
  6.6.2 Brazil Head and Neck Cancer Drugs/Therapeutics Market Size, 2017-2028
  6.6.3 Argentina Head and Neck Cancer Drugs/Therapeutics Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Head and Neck Cancer Drugs/Therapeutics Revenue, 2017-2028
  6.7.2 Turkey Head and Neck Cancer Drugs/Therapeutics Market Size, 2017-2028
  6.7.3 Israel Head and Neck Cancer Drugs/Therapeutics Market Size, 2017-2028
  6.7.4 Saudi Arabia Head and Neck Cancer Drugs/Therapeutics Market Size, 2017-2028
  6.7.5 UAE Head and Neck Cancer Drugs/Therapeutics Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Sanofi
  7.1.1 Sanofi Corporate Summary
  7.1.2 Sanofi Business Overview
  7.1.3 Sanofi Head and Neck Cancer Drugs/Therapeutics Major Product Offerings
  7.1.4 Sanofi Head and Neck Cancer Drugs/Therapeutics Revenue in Global Market (2017-2022)
  7.1.5 Sanofi Key News
7.2 Eli Lilly
  7.2.1 Eli Lilly Corporate Summary
  7.2.2 Eli Lilly Business Overview
  7.2.3 Eli Lilly Head and Neck Cancer Drugs/Therapeutics Major Product Offerings
  7.2.4 Eli Lilly Head and Neck Cancer Drugs/Therapeutics Revenue in Global Market (2017-2022)
  7.2.5 Eli Lilly Key News
7.3 Amgen
  7.3.1 Amgen Corporate Summary
  7.3.2 Amgen Business Overview
  7.3.3 Amgen Head and Neck Cancer Drugs/Therapeutics Major Product Offerings
  7.3.4 Amgen Head and Neck Cancer Drugs/Therapeutics Revenue in Global Market (2017-2022)
  7.3.5 Amgen Key News
7.4 Actavis
  7.4.1 Actavis Corporate Summary
  7.4.2 Actavis Business Overview
  7.4.3 Actavis Head and Neck Cancer Drugs/Therapeutics Major Product Offerings
  7.4.4 Actavis Head and Neck Cancer Drugs/Therapeutics Revenue in Global Market (2017-2022)
  7.4.5 Actavis Key News
7.5 Dr. Reddy’s Laboratories
  7.5.1 Dr. Reddy’s Laboratories Corporate Summary
  7.5.2 Dr. Reddy’s Laboratories Business Overview
  7.5.3 Dr. Reddy’s Laboratories Head and Neck Cancer Drugs/Therapeutics Major Product Offerings
  7.5.4 Dr. Reddy’s Laboratories Head and Neck Cancer Drugs/Therapeutics Revenue in Global Market (2017-2022)
  7.5.5 Dr. Reddy’s Laboratories Key News
7.6 Jiangsu Hengrui
  7.6.1 Jiangsu Hengrui Corporate Summary
  7.6.2 Jiangsu Hengrui Business Overview
  7.6.3 Jiangsu Hengrui Head and Neck Cancer Drugs/Therapeutics Major Product Offerings
  7.6.4 Jiangsu Hengrui Head and Neck Cancer Drugs/Therapeutics Revenue in Global Market (2017-2022)
  7.6.5 Jiangsu Hengrui Key News
7.7 Teva Pharmaceutical
  7.7.1 Teva Pharmaceutical Corporate Summary
  7.7.2 Teva Pharmaceutical Business Overview
  7.7.3 Teva Pharmaceutical Head and Neck Cancer Drugs/Therapeutics Major Product Offerings
  7.7.4 Teva Pharmaceutical Head and Neck Cancer Drugs/Therapeutics Revenue in Global Market (2017-2022)
  7.7.5 Teva Pharmaceutical Key News
7.8 DFG
  7.8.1 DFG Corporate Summary
  7.8.2 DFG Business Overview
  7.8.3 DFG Head and Neck Cancer Drugs/Therapeutics Major Product Offerings
  7.8.4 DFG Head and Neck Cancer Drugs/Therapeutics Revenue in Global Market (2017-2022)
  7.8.5 DFG Key News
7.9 BioXpress
  7.9.1 BioXpress Corporate Summary
  7.9.2 BioXpress Business Overview
  7.9.3 BioXpress Head and Neck Cancer Drugs/Therapeutics Major Product Offerings
  7.9.4 BioXpress Head and Neck Cancer Drugs/Therapeutics Revenue in Global Market (2017-2022)
  7.9.5 BioXpress Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Head and Neck Cancer Drugs/Therapeutics Market Opportunities & Trends in Global Market
Table 2. Head and Neck Cancer Drugs/Therapeutics Market Drivers in Global Market
Table 3. Head and Neck Cancer Drugs/Therapeutics Market Restraints in Global Market
Table 4. Key Players of Head and Neck Cancer Drugs/Therapeutics in Global Market
Table 5. Top Head and Neck Cancer Drugs/Therapeutics Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Head and Neck Cancer Drugs/Therapeutics Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Head and Neck Cancer Drugs/Therapeutics Revenue Share by Companies, 2017-2022
Table 8. Global Companies Head and Neck Cancer Drugs/Therapeutics Product Type
Table 9. List of Global Tier 1 Head and Neck Cancer Drugs/Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Head and Neck Cancer Drugs/Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Head and Neck Cancer Drugs/Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Head and Neck Cancer Drugs/Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Head and Neck Cancer Drugs/Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Head and Neck Cancer Drugs/Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Head and Neck Cancer Drugs/Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Head and Neck Cancer Drugs/Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Head and Neck Cancer Drugs/Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Head and Neck Cancer Drugs/Therapeutics Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Head and Neck Cancer Drugs/Therapeutics Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Head and Neck Cancer Drugs/Therapeutics Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Head and Neck Cancer Drugs/Therapeutics Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Head and Neck Cancer Drugs/Therapeutics Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Head and Neck Cancer Drugs/Therapeutics Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Head and Neck Cancer Drugs/Therapeutics Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Head and Neck Cancer Drugs/Therapeutics Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Head and Neck Cancer Drugs/Therapeutics Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Head and Neck Cancer Drugs/Therapeutics Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Head and Neck Cancer Drugs/Therapeutics Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Head and Neck Cancer Drugs/Therapeutics Revenue, (US$, Mn), 2023-2028
Table 30. Sanofi Corporate Summary
Table 31. Sanofi Head and Neck Cancer Drugs/Therapeutics Product Offerings
Table 32. Sanofi Head and Neck Cancer Drugs/Therapeutics Revenue (US$, Mn), (2017-2022)
Table 33. Eli Lilly Corporate Summary
Table 34. Eli Lilly Head and Neck Cancer Drugs/Therapeutics Product Offerings
Table 35. Eli Lilly Head and Neck Cancer Drugs/Therapeutics Revenue (US$, Mn), (2017-2022)
Table 36. Amgen Corporate Summary
Table 37. Amgen Head and Neck Cancer Drugs/Therapeutics Product Offerings
Table 38. Amgen Head and Neck Cancer Drugs/Therapeutics Revenue (US$, Mn), (2017-2022)
Table 39. Actavis Corporate Summary
Table 40. Actavis Head and Neck Cancer Drugs/Therapeutics Product Offerings
Table 41. Actavis Head and Neck Cancer Drugs/Therapeutics Revenue (US$, Mn), (2017-2022)
Table 42. Dr. Reddy’s Laboratories Corporate Summary
Table 43. Dr. Reddy’s Laboratories Head and Neck Cancer Drugs/Therapeutics Product Offerings
Table 44. Dr. Reddy’s Laboratories Head and Neck Cancer Drugs/Therapeutics Revenue (US$, Mn), (2017-2022)
Table 45. Jiangsu Hengrui Corporate Summary
Table 46. Jiangsu Hengrui Head and Neck Cancer Drugs/Therapeutics Product Offerings
Table 47. Jiangsu Hengrui Head and Neck Cancer Drugs/Therapeutics Revenue (US$, Mn), (2017-2022)
Table 48. Teva Pharmaceutical Corporate Summary
Table 49. Teva Pharmaceutical Head and Neck Cancer Drugs/Therapeutics Product Offerings
Table 50. Teva Pharmaceutical Head and Neck Cancer Drugs/Therapeutics Revenue (US$, Mn), (2017-2022)
Table 51. DFG Corporate Summary
Table 52. DFG Head and Neck Cancer Drugs/Therapeutics Product Offerings
Table 53. DFG Head and Neck Cancer Drugs/Therapeutics Revenue (US$, Mn), (2017-2022)
Table 54. BioXpress Corporate Summary
Table 55. BioXpress Head and Neck Cancer Drugs/Therapeutics Product Offerings
Table 56. BioXpress Head and Neck Cancer Drugs/Therapeutics Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Head and Neck Cancer Drugs/Therapeutics Segment by Type in 2021
Figure 2. Head and Neck Cancer Drugs/Therapeutics Segment by Application in 2021
Figure 3. Global Head and Neck Cancer Drugs/Therapeutics Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Head and Neck Cancer Drugs/Therapeutics Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Head and Neck Cancer Drugs/Therapeutics Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Head and Neck Cancer Drugs/Therapeutics Revenue in 2021
Figure 8. By Type - Global Head and Neck Cancer Drugs/Therapeutics Revenue Market Share, 2017-2028
Figure 9. By Application - Global Head and Neck Cancer Drugs/Therapeutics Revenue Market Share, 2017-2028
Figure 10. By Region - Global Head and Neck Cancer Drugs/Therapeutics Revenue Market Share, 2017-2028
Figure 11. By Country - North America Head and Neck Cancer Drugs/Therapeutics Revenue Market Share, 2017-2028
Figure 12. US Head and Neck Cancer Drugs/Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Head and Neck Cancer Drugs/Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Head and Neck Cancer Drugs/Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Head and Neck Cancer Drugs/Therapeutics Revenue Market Share, 2017-2028
Figure 16. Germany Head and Neck Cancer Drugs/Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 17. France Head and Neck Cancer Drugs/Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Head and Neck Cancer Drugs/Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Head and Neck Cancer Drugs/Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Head and Neck Cancer Drugs/Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Head and Neck Cancer Drugs/Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Head and Neck Cancer Drugs/Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Head and Neck Cancer Drugs/Therapeutics Revenue Market Share, 2017-2028
Figure 24. China Head and Neck Cancer Drugs/Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Head and Neck Cancer Drugs/Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Head and Neck Cancer Drugs/Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Head and Neck Cancer Drugs/Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 28. India Head and Neck Cancer Drugs/Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Head and Neck Cancer Drugs/Therapeutics Revenue Market Share, 2017-2028
Figure 30. Brazil Head and Neck Cancer Drugs/Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Head and Neck Cancer Drugs/Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Head and Neck Cancer Drugs/Therapeutics Revenue Market Share, 2017-2028
Figure 33. Turkey Head and Neck Cancer Drugs/Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Head and Neck Cancer Drugs/Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Head and Neck Cancer Drugs/Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Head and Neck Cancer Drugs/Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 37. Sanofi Head and Neck Cancer Drugs/Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Eli Lilly Head and Neck Cancer Drugs/Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Amgen Head and Neck Cancer Drugs/Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Actavis Head and Neck Cancer Drugs/Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Dr. Reddy’s Laboratories Head and Neck Cancer Drugs/Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Jiangsu Hengrui Head and Neck Cancer Drugs/Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Teva Pharmaceutical Head and Neck Cancer Drugs/Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. DFG Head and Neck Cancer Drugs/Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. BioXpress Head and Neck Cancer Drugs/Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)